Organigram Holdings Inc. (NASDAQ:OGI – Get Free Report)’s stock price fell 1.3% on Friday . The company traded as low as $1.53 and last traded at $1.55. 250,374 shares changed hands during trading, a decline of 53% from the average session volume of 534,901 shares. The stock had previously closed at $1.57.
Organigram Stock Performance
The stock has a market cap of $195.54 million, a P/E ratio of -4.08 and a beta of 1.00. The firm’s fifty day simple moving average is $1.55 and its 200-day simple moving average is $1.68.
Organigram (NASDAQ:OGI – Get Free Report) last released its earnings results on Wednesday, December 18th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($0.01). Organigram had a negative net margin of 28.58% and a negative return on equity of 11.68%. Analysts predict that Organigram Holdings Inc. will post -0.09 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Organigram
Organigram Company Profile
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Recommended Stories
- Five stocks we like better than Organigram
- Investing in Travel Stocks Benefits
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Insider Selling Explained: Can it Inform Your Investing Choices?
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Ride Out The Recession With These Dividend Kings
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.